Showing 1,501 - 1,520 results of 3,189 for search '"vaccination"', query time: 0.06s Refine Results
  1. 1501
  2. 1502

    Assessment of COVID-19 vaccine uptake and associated factors among healthcare workers in selected health facilities of the Somali Region, Eastern Ethiopia: a cross-sectional study conducted in 2021 by Maereg Wolde, Trhas Tadesse Berhe, Addisalem Melesse, Rachana Sharma, Hnin Su Mon, Tesfaye Simireta, Hailemariam Addisu, Yosef Wassihun

    Published 2024-07-01
    “…Background The global COVID-19 pandemic poses substantial health challenges. Vaccination is key in preventing COVID-19, particularly among healthcare workers (HCWs), essential in curbing the pandemic. …”
    Get full text
    Article
  3. 1503
  4. 1504
  5. 1505
  6. 1506

    Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. by Vicente P Martins, Suellen B Morais, Carina S Pinheiro, Natan R G Assis, Barbara C P Figueiredo, Natasha D Ricci, Juliana Alves-Silva, Marcelo V Caliari, Sergio C Oliveira

    Published 2014-03-01
    “…<h4>Conclusions/significance</h4>Our data suggest that Sm10.3 is a potential candidate for use in developing a multi-antigen vaccine to control schistosomiasis and provide the first evidence for a possible role for Sm10.3 in the blood feeding process.…”
    Get full text
    Article
  7. 1507
  8. 1508
  9. 1509

    Transient Pneumonitis as a Possible Adverse Reaction to the BNT162b2 COVID-19 mRNA Vaccine in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature by Yusuke Ohkubo, Shin-ichiro Ohmura, Ryuhei Ishihara, Toshiaki Miyamoto

    Published 2022-01-01
    “…The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to rapid progress in vaccine development to prevent the spread of the disease. …”
    Get full text
    Article
  10. 1510

    Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults. by David J Diemert, Maria Zumer, Mark Bova, Christina Gibbs-Tewary, Elissa M Malkin, Doreen Campbell, Lara Hoeweler, Guangzhao Li, Maria Elena Bottazzi, Peter J Hotez, Jeffrey M Bethony

    Published 2024-12-01
    “…Phase 1 trials have demonstrated the safety of Na-GST-1 formulated on Alhydrogel, but further optimization of the vaccine adjuvant formulation may improve humoral immune responses, thereby increasing the likelihood of vaccine efficacy.…”
    Get full text
    Article
  11. 1511

    A descriptive-multivariate analysis of community knowledge, confidence, and trust in COVID-19 clinical trials amongst Ugandans working in healthcare settings. by Keneth Iceland, Kasozi, Lawrence Obado, Osuwat

    Published 2021
    Subjects: “…COVID-19 clinical trials in resource poor countries; COVID-19 vaccines; Clinical trials in Africa; COVID-19 and medical workers; vaccines, Oxford-AstraZeneca.…”
    Get full text
    Article
  12. 1512
  13. 1513
  14. 1514

    ENHANCING OF IMMUNE RESPONSE AGAINST NEWCASTLE DISEASE VIRUS FOR BROILER FEEDS ON ZINC-METHIONINE by Wejdan. M. A., B. H. Ali

    Published 2025-01-01
    Subjects: “…element, amino acid,poultry,vaccine ,bursal index and spleen index.…”
    Get full text
    Article
  15. 1515
  16. 1516
  17. 1517
  18. 1518
  19. 1519
  20. 1520